Alcohol-Induced Liver Disease: Clinical, Molecular Mechanism, Pathology, Therapeutics

Dear Colleagues,

Alcohol-induced Liver Disease (ALD) is presented as steatosis caused by alcohol misuse. Often, ALD occurs in conjunction with other metabolic disorders such as high cholesterol, obesity, and diabetes. ALD is underdiagnosed due to a lack of evidence of heavy drinking or symptoms. Alcoholic Steatohepatitis (ASH) is a severe form of ALD, where fibrosis of the liver tissue occurs. It is a serious condition that can progress to cirrhosis and potentially result in the need for liver transplantation or death. 

Other possible subjects include the following:

1. Consumption of alcoholic beverages belongs to the everyday "diet" in many countries, independent of the time of the day, during meals or outside of the meals, and independent of the type of alcohol. This has to be taken into account when approaching a patient with ALD. Often, in fact, it may be difficult to diagnose a pure alcoholic liver disease, to establish a follow-up schedule to eventually prevent liver cirrhosis and cancer development.
2. History of liver cirrhosis and HCC development before and after the era of viral hepatitis in the Western world.
3. Alcoholic beverage and tobacco consumption: synergistic damaging noxae?
4. ALD and distilled alcoholic beverages.
5. Diagnostic tests of alcohol consumption.
6. Animal models of alcoholic liver damage.
7. Sugar (glucose, fructose, xylose) and alcohol consumption synergistic effects in liver damage.

Prof. Dr. Giuliano Ramadori
Prof. Dr. Manuela G. Neuman
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Livers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• alcohol-induced liver damage
• acute alcoholic hepatitis
• viruses and alcohol drinking
• models of alcohol toxicity
• hyper-glycemia and alcohol
• fructose, glucose and alcohol liver disease
• role of alcohol industry in safe drinking